Tate Prime Review

About Tate Prime

Tate Prime operates or operated via the domain tateprime.com. It claims affiliation with IC Markets and asserts regulation by ASIC (Australia), CySEC (Cyprus), and the Seychelles FSA. However, these regulatory claims are unverified: no evidence links Tate Prime to any valid license, and the regulators do not list it as authorized. The Cyprus-based license number 362/18 is confirmed to be used in a clone scam. Similarly, the ASIC and Seychelles FSA claims remain unverified, and the promoters are not found in official registries. Domain availability has been flagged as suspended, underscoring operational instability.  

Regulators have explicitly identified Tate Prime as a clone of IC Markets, with no legitimate connection to that firm. Physical address visits in both Cyprus and Australia found no office at the provided locations. The broker’s web presence has been reported as suspended. Multiple user reports and forum testimonies describe customer losses due to requested security bonds, taxes, and inability to withdraw funds.   

Pros and cons

Cons

• False regulatory claims and confirmed clone status, including misrepresentation of CySEC license 362/18 (clone of IC Markets) 
• No verifiable regulation by ASIC, CySEC, or Seychelles FSA 
• No physical office found at declared addresses in Australia or Cyprus 
• Domain suspended or unavailable, indicating potential operational shutdown 
• Numerous user reports of withdrawal issues, demands for extra funds (security bonds, “taxes”), and disappearance of support